Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GHL
2801
DELISTED
Greenhill & Co., Inc.
GHL
| $2.13M | ﹤0.01% |
212,731
-8,001
| -4% | -$79K |
|
2802
X4 Pharmaceuticals
XFOR
$386M
| $2.12M | ﹤0.01% |
7,599
+618
| +9% | +$169K |
|
2803
AMES National
ATLO
$274M
| $2.12M | ﹤0.01% |
107,573
+3,739
| +4% | +$73.1K |
|
|
WMC
2804
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $2.12M | ﹤0.01% |
77,398
+3,073
| +4% | +$78.7K |
|
2805
Northeast Bank
NBN
$1.13B
| $2.12M | ﹤0.01% |
120,623
-66
| -0.1% | -$1K |
|
|
KDNY
2806
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.11M | ﹤0.01% |
182,742
+1,341
| +0.7% | +$18.5K |
|
2807
Rafael Holdings
RFL
$104M
| $2.1M | ﹤0.01% |
148,510
-225
| -0.2% | -$3.1K |
|
2808
Dianthus Therapeutics
DNTH
$5.8B
| $2.1M | ﹤0.01% |
17,495
+555
| +3% | +$78.2K |
|
2809
INNOVATE Corp
VATE
$99.6M
| $2.1M | ﹤0.01% |
62,802
+27,761
| +79% | +$785K |
|
2810
Millicom
TIGO
$15.8B
| $2.09M | ﹤0.01% |
80,103
+8,440
| +12% | +$219K |
|
2811
Caesarstone
CSTE
$75.4M
| $2.09M | ﹤0.01% |
176,728
+6,832
| +4% | +$71.9K |
|
2812
Pulse Biosciences
PLSE
$2.61B
| $2.09M | ﹤0.01% |
200,057
+34,346
| +21% | +$309K |
|
|
FCBP
2813
DELISTED
First Choice Bancorp Common Stock
FCBP
| $2.08M | ﹤0.01% |
126,699
+3,383
| +3% | +$49.2K |
|
2814
Weyco Group
WEYS
$385M
| $2.07M | ﹤0.01% |
96,017
+2,223
| +2% | +$43.2K |
|
|
EGLE
2815
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $2.07M | ﹤0.01% |
135,012
-1,073
| -0.8% | -$14.4K |
|
|
SNCR
2816
DELISTED
Synchronoss Technologies
SNCR
| $2.06M | ﹤0.01% |
64,843
+196
| +0.3% | +$5.41K |
|
2817
Cabaletta Bio
CABA
$439M
| $2.06M | ﹤0.01% |
184,700
+36,492
| +25% | +$279K |
|
|
PWOD
2818
DELISTED
Penns Woods Bancorp
PWOD
| $2.06M | ﹤0.01% |
90,567
+2,994
| +3% | +$66.8K |
|
2819
Prudential
PUK
$37.4B
| $2.06M | ﹤0.01% |
69,758
+4,798
| +7% | +$127K |
|
2820
RCI Hospitality Holdings
RICK
$192M
| $2.05M | ﹤0.01% |
148,216
+5,171
| +4% | +$63.2K |
|
2821
InfuSystem Holdings
INFU
$186M
| $2.04M | ﹤0.01% |
177,141
+95,182
| +116% | +$1.09M |
|
2822
Cartesian Therapeutics
RNAC
$231M
| $2.04M | ﹤0.01% |
23,970
+14,447
| +152% | +$1.31M |
|
2823
Sutro Biopharma
STRO
$416M
| $2.04M | ﹤0.01% |
26,232
+14,287
| +120% | +$1.37M |
|
2824
Mirum Pharmaceuticals
MIRM
$6.38B
| $2.03M | ﹤0.01% |
104,540
+11,182
| +12% | +$187K |
|
|
BPYU
2825
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $2.03M | ﹤0.01% |
204,024
+9,743
| +5% | +$98K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.